Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide

BACKGROUND: Teriflunomide 14 mg significantly reduced brain volume loss (BVL) and confirmed disability worsening (CDW) compared with placebo in the TEMSO core study. OBJECTIVE: To investigate the relationship between BVL from Baseline to Year 2 in the TEMSO core study and long-term CDW (Year 7) in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprenger, Till, Kappos, Ludwig, Radue, Ernst-Wilhelm, Gaetano, Laura, Mueller-Lenke, Nicole, Wuerfel, Jens, Poole, Elizabeth M, Cavalier, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493202/
https://www.ncbi.nlm.nih.gov/pubmed/31198103
http://dx.doi.org/10.1177/1352458519855722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493202/
https://www.ncbi.nlm.nih.gov/pubmed/31198103
http://dx.doi.org/10.1177/1352458519855722

Ejemplares similares